Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Prime Medicine (PRME) FCF Margin (2024 - 2025)

Prime Medicine filings provide 2 years of FCF Margin readings, the most recent being 3953.34% for Q4 2025.

  • On a quarterly basis, FCF Margin fell 489672.0% to 3953.34% in Q4 2025 year-over-year; TTM through Dec 2025 was 3512.05%, a 64548.0% increase, with the full-year FY2025 number at 3512.05%, up 64548.0% from a year prior.
  • FCF Margin hit 3953.34% in Q4 2025 for Prime Medicine, down from 2880.49% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 943.38% in Q4 2024 to a low of 13009.09% in Q3 2024.